Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, et al. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology. 2013;38(4):552-62. DOI: 10.1038/npp.2012.204. PubMed PMID: 23072836; PubMed Central PMCID: PMC3572453.

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.

Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M, et al. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron. 2008;57(2):203-9. DOI: 10.1016/j.neuron.2007.11.017. PubMed PMID: 18215618.

Epigenetic GABAergic targets in schizophrenia and bipolar disorder.

Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, et al. Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology. 2011;60(7-8):1007-16. DOI: 10.1016/j.neuropharm.2010.10.021. PubMed PMID: 21074545; PubMed Central PMCID: PMC4144274.

Role for the Clock gene in bipolar disorder.

McClung CA. Role for the Clock gene in bipolar disorder. Cold Spring Harb Symp Quant Biol. 2007;72:637-44. DOI: 10.1101/sqb.2007.72.031. PubMed PMID: 18419323.

Perceptions of epigenetics.

Bird A. Perceptions of epigenetics. Nature. 2007;447(7143):396-8. DOI: 10.1038/nature05913. PubMed PMID: 17522671.

Schizophrenia risk from complex variation of complement component 4.

Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530(7589):177-83. DOI: 10.1038/nature16549. PubMed PMID: 26814963; PubMed Central PMCID: PMC4752392.

Automated design of ligands to polypharmacological profiles.

Besnard J, Ruda GF, Setola V, Abecassis K, Rodriguiz RM, Huang X-P, et al. Automated design of ligands to polypharmacological profiles. Nature. 2012;492(7428):215-20. DOI: 10.1038/nature11691. PubMed PMID: 23235874; PubMed Central PMCID: PMC3653568.

Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels.

Schuwald AM, Nöldner M, Wilmes T, Klugbauer N, Leuner K, Müller WE. Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels. Plos One. 2013;8(4):e59998. DOI: 10.1371/journal.pone.0059998. PubMed PMID: 23637742; PubMed Central PMCID: PMC3639265.

Anosmia does not impair the anxiolytic-like effect of lavender essential oil inhalation in mice.

Chioca LR, Antunes VDC, Ferro MM, Losso EM, Andreatini R. Anosmia does not impair the anxiolytic-like effect of lavender essential oil inhalation in mice. Life Sci. 2013;92(20-21):971-5. DOI: 10.1016/j.lfs.2013.03.012. PubMed PMID: 23567808.

The serotonin-1A receptor in anxiety disorders.

Akimova E, Lanzenberger R, Kasper S. The serotonin-1A receptor in anxiety disorders. Biological Psychiatry. 2009;66(7):627-35. DOI: 10.1016/j.biopsych.2009.03.012. PubMed PMID: 19423077.